Aart‐Jan van der Lely

The Novel Somatostatin Analog SOM230 Is a Potent Inhibitor of Hormone Release by Growth Hormone- and Prolactin-Secreting Pituitary Adenomas<i>in Vitro</i>

Leo J. Hofland, Joost van der Hoek, Peter M. van Koetsveld et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 180 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells

Virgil A. S. H. Dalm, P. Martin van Hagen, Peter M. van Koetsveld et al. · American Journal of Physiology-Endocrinology and Metabolism · 2003 · 174 citations

Life Sciences, Immunology, Molecular Biology +16

Long-Term Efficacy and Safety of Combined Treatment of Somatostatin Analogs and Pegvisomant in Acromegaly

Sebastian Neggers, Maarten O. van Aken, J. A. M. J. L. Janssen et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 157 citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +10

A Single-Dose Comparison of the Acute Effects between the New Somatostatin Analog SOM230 and Octreotide in Acromegalic Patients

Joost van der Hoek, Wouter W. de Herder, Richard A. Feelders et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 142 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Unacylated Ghrelin Rapidly Modulates Lipogenic and Insulin Signaling Pathway Gene Expression in Metabolically Active Tissues of GHSR Deleted Mice

Patric J. D. Delhanty, Yuxiang Sun, Jenny A. Visser et al. · PLoS ONE · 2010 · 127 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +17